PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.65%
Negative revenue growth while ECL.AX stands at 11.08%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-18.11%
Negative gross profit growth while ECL.AX is at 23.87%. Joel Greenblatt would examine cost competitiveness or demand decline.
-140.60%
Negative EBIT growth while ECL.AX is at 23.90%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-140.60%
Negative operating income growth while ECL.AX is at 23.90%. Joel Greenblatt would press for urgent turnaround measures.
-103.99%
Negative net income growth while ECL.AX stands at 104.45%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-100.00%
Negative EPS growth while ECL.AX is at 107.33%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-100.00%
Negative diluted EPS growth while ECL.AX is at 107.33%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-16.26%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-12.92%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-23.93%
Negative OCF growth while ECL.AX is at 111.46%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-23.16%
Negative FCF growth while ECL.AX is at 111.13%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-78.54%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-49.63%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
4.52%
3Y revenue/share CAGR under 50% of ECL.AX's 34.45%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
151.16%
Positive long-term OCF/share growth while ECL.AX is negative. John Neff would see a structural advantage in sustained cash generation.
407.95%
Positive OCF/share growth while ECL.AX is negative. John Neff might see a comparative advantage in operational cash viability.
31.81%
Positive 3Y OCF/share CAGR while ECL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
98.36%
Below 50% of ECL.AX's 239.10%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-146.54%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
84.00%
3Y net income/share CAGR above 1.5x ECL.AX's 41.30%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1408.92%
Positive short-term equity growth while ECL.AX is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.38%
Firm’s AR is declining while ECL.AX shows 5.49%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.37%
Inventory is declining while ECL.AX stands at 13.27%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.51%
Similar asset growth to ECL.AX's 4.83%. Walter Schloss finds parallel expansions or investment rates.
39.13%
BV/share growth above 1.5x ECL.AX's 5.52%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-58.69%
We’re deleveraging while ECL.AX stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
42.47%
SG&A growth well above ECL.AX's 29.09%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.